NASDAQ$NEOG

Neogen Corporation · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Neogen's Q1 2024 results were announced, featuring a significant revenue increase driven by the 3M Food Safety Division merger, alongside a decrease in net income due to related expenses.

Neogen reported a 73% increase in revenue to $229.0 million, driven by the acquisition of the 3M Food Safety Division. However, net income decreased to $1.5 million, or $0.01 per diluted share, due to increased interest expense and amortization of acquisition-related intangibles. Adjusted EBITDA increased by 93.8% to $52.4 million, with a margin of 22.9%.

  • Revenue increased by 73.0% year-over-year to $229.0 million, primarily due to the acquisition of the 3M Food Safety Division.
  • Net income decreased to $1.5 million, or $0.01 per diluted share, impacted by expenses related to the 3M Food Safety merger.
  • Adjusted EBITDA rose by 93.8% to $52.4 million, with a margin of 22.9%.
  • Food Safety segment revenue increased significantly, while the Animal Safety segment experienced a core revenue decline due to destocking.

Headline financials

Total Revenue

$229M

Previous: $132M+73.0%
EPS (adj)

$0.11

Previous: $0.15-26.7%
Adj. EBITDA Margin

22.9%

No prior period
Core Revenue Growth

-1.3%

No prior period
Capital Expenditures

-$30.6M

No prior period
Free Cash Flow

$1.5M

Previous: $5.21M-71.1%
Net Income

$1.5M

Previous: $5.21M-71.1%
Operating Income

$19.1M

Previous: $6.06M+215.7%
Gross Profit

$117M

Previous: $62.3M+87.5%
Cash & Equivalents

$179M

Previous: $348M-48.6%
Total Assets

$4.56B

Previous: $977M+366.7%
Stock-Based Comp

$2.64M

Previous: $1.87M+41.3%

Revenue & EPS history

Neogen · Revenue · Quarterly

$229M

Q1 2024+73%vs Q1 2023
Beat estimate in 9 of 14 quarters(64%)
ActualEstimate

Revenue by segment

Neogen · $229M total across 2 segments · Q1 2024

  • Food Safety
    $166M+157.3%
  • Animal Safety
    $62.7M-7.4%

Forward guidance

Neogen anticipates fiscal year 2024 revenue between $955 million and $985 million, while Adjusted EBITDA continues to be expected in a range of $235 million to $255 million. The Company also continues to expect capital expenditures to be approximately $130 million, including approximately $100 million related specifically to the integration of the former 3M Food Safety Division.

Tailwinds

  • Fiscal year 2024 revenue is anticipated to be between $955 million and $985 million.
  • Adjusted EBITDA is expected to be in the range of $235 million to $255 million.
  • Improved end-market environment expected in the second half of the year.
  • Capital expenditures are projected to be approximately $130 million.
  • Integration of the former 3M Food Safety Division is progressing well.

Headwinds

  • Typical seasonality of revenue may impact performance.
  • Capital expenditures include approximately $100 million related to the integration of the former 3M Food Safety Division.
  • Animal Safety business experienced continued destocking.
  • Weakness in China impacted pro forma growth in the former 3M Food Safety Division.
  • The Indicator Testing, Culture Media & Other product category experienced a core revenue decline.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

-1.4%

Avg return

Earnings day

-2.4%

Avg return

5 days after

-1.8%

Avg return

30 days after

36%

23 / 64 earnings

Positive

+31.5%

Q2 2026

Best reaction

-28.7%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026+3.9%-7.1%-12.5%
Q2 2026+31.5%+24.5%+46.3%
Q1 2026+16.4%+1.5%+10.0%
Q3 2025-28.7%-23.3%-15.2%
Q2 2025-3.3%-13.1%-20.7%
Q1 2025-2.8%-0.8%+9.3%
Q4 2024-1.6%-5.3%-1.0%
Q3 2024-13.1%-13.9%-13.6%
Q2 2024-5.5%-8.4%-18.0%
Q1 2024-11.7%-8.8%-11.0%
Q4 2023+2.3%+0.0%+0.8%
Q3 2023+0.2%-3.6%-6.9%
Q2 2023+5.1%+11.2%+30.3%
Q1 2023-1.0%-4.1%-12.2%
Q4 2022+8.0%+7.5%-2.8%
Q3 2022-7.4%-5.3%-15.3%
Q2 2022+1.4%+0.2%-19.2%
Q1 2022+3.0%+6.1%+2.9%
Q4 2021+0.2%-1.9%-3.6%
Q3 2021+3.0%+5.6%+14.9%
Q2 2021+1.2%+0.5%+3.8%
Q1 2021+0.2%+1.1%-4.3%
Q4 2020-4.0%-4.0%-2.9%
Q3 2020-5.3%-1.2%+8.1%
Q2 2020-5.4%-5.7%+1.2%
Q1 2020-10.6%-13.0%-13.1%
Q4 2019+9.0%+10.6%+13.2%
Q3 2019-8.3%-5.2%-4.4%
Q2 2019-8.1%-10.7%+2.4%
Q1 2019-17.8%-19.3%-30.4%
Q4 2018+1.5%+1.7%+3.9%
Q3 2018-4.2%+1.0%+7.6%
Q2 2018-0.8%-0.7%-1.8%
Q1 2018-4.4%-1.5%+6.4%
Q4 2017-2.2%-1.8%-4.5%
Q3 2017-5.9%-6.7%-9.8%
Q2 2017+3.8%+5.6%+0.5%
Q1 2017-4.7%-2.8%-10.1%
Q4 2016-1.6%-1.8%-0.4%
Q3 2016-14.6%
Q2 2016-2.0%
Q1 2016-12.1%
Q4 2015+25.2%
Q3 2015-3.4%
Q2 2015+1.2%
Q1 2015-1.7%
Q4 2014+11.3%
Q3 2014-0.1%
Q2 2014-5.6%
Q1 2014-0.3%
Q4 2013-4.9%
Q3 2013+0.5%
Q2 2013-0.7%
Q1 2013+7.5%
Q4 2010-2.9%
Q4 2012-2.9%
Q3 2012-0.3%
Q3 2011-0.3%
Q2 2011+2.5%
Q2 2012+2.5%
Q4 2011-7.3%
Q1 2011-7.3%
Q1 2012-7.3%
Q3 2010-0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro